Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s):  AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N-Dimethyltryptamine (DMT). The Company operates through two segments, which includes the development of repurposed therapeutic drugs in Canada and the facilitation of the Company’s lead drug candidates into off-label phase II clinical trials (humans) in Australia. The Company's pipeline includes NP-251 (Repirinast) and AP-188 (DMT). The Company, through its subsidiary, Algernon NeuroScience Inc., is developing AP-188 (DMT) as a potential treatment for stroke and traumatic brain injury (TBI) recovery. Its NP-251 is being developed as a potential treatment for kidney inflammation and fibrosis.


CSE:AGN - Post by User

Post by Sylvain123on Aug 26, 2020 6:51am
243 Views
Post# 31453914

He says so many things to himself, but what's the truth!

He says so many things to himself, but what's the truth!
 
As far as I'm concerned, many medications have not worked so far, but Ifenprodil, which has proven its worth over the past 50 years, is still the best. It is clear that the therapy developed by AGN will gain points and will be used to heal and help healing. AGN is still in the running despite everything that is happening. It seems long, but developing a therapy, a medication is always a long process. Don't forget that Trump has been talking nonsense for months, he's making a fool of himself. His story about a vaccine or something else is smoke and mirrors, but AGN is continuing without making any waves and that impresses me and makes this company more and more interesting and serious in my eyes.  My investment is in good hands, the next few weeks we will tell how AGN or how much AGN will make us earn.
 
 
<< Previous
Bullboard Posts
Next >>